Isomorphic Labs seeks major funding round for computational drug discovery

Alphabet spin off Isomorphic Labs is in discussions to raise five billion dollars in new funding, targeting a valuation of fifty billion dollars. The startup uses artificial intelligence algorithms to assist in discovering pharmaceutical treatments and biological compounds. The move reflects Google's focus on commercializing deep learning applications in healthcare.